Search - tctmd.com

Displaying 121 - 140 of 274

Sort: Relevancy | Date

News Daily News

Latest Observational Data Support TAVR Durability Through 7 Years

Caitlin E. Cox

April 12, 2019

News Daily News

Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study

L.A. McKeown

March 29, 2019

News Daily News

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Michael O'Riordan

March 27, 2019

News Daily News

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

Yael L. Maxwell

March 01, 2019

News Daily News

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Shelley Wood

February 19, 2019

News Daily News

Less Bivalirudin, Minimal Ultrasound: Survey Highlights Global Transradial Practice Patterns

Michael O'Riordan

November 28, 2018

News Daily News

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Todd Neale

November 20, 2018

News Daily News

Procedural Success Increasing for CTO PCI in Europe, Despite More Complex Lesions

Yael L. Maxwell

October 15, 2018

News Daily News

TAVR Superior to Surgery at Getting High-Risk Patients Home Sooner

Michael O'Riordan

September 20, 2018

News Daily News

Aging Data: Study Highlights Delays From Time of Clinical Trial Enrollment to Publication

Yael L. Maxwell

August 15, 2018

News Daily News

No Harm Done: Foregoing Routine TEE and General Anesthesia in TAVR

Caitlin E. Cox

July 17, 2018

News Daily News

Norepinephrine Bests Epinephrine in Battle of the Vasopressors in Cardiogenic Shock

L.A. McKeown

July 03, 2018

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

News Daily News

iFR Pullback Provides Roadmap for CAD Severity, Predicts Hemodynamics Post-PCI

Caitlin E. Cox

April 17, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for January 2018

Shelley Wood

January 31, 2018

News Daily News

Preexisting Prosthesis-Patient Mismatch Signals Worse Aortic Valve-in-Valve Outcomes

Todd Neale

January 17, 2018

News Daily News

Low Rate of Bailout Emergency Surgery During TAVR, but Caution Still Needed

Michael O'Riordan

January 10, 2018

News Daily News

REPRISE III in Print: Now With Comparison Between Lotus, Evolut R

Shelley Wood

January 05, 2018

News Daily News

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

Caitlin E. Cox

November 30, 2017

News Daily News

Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria

Caitlin E. Cox

October 18, 2017

Advertisement

Latest Observational Data Support TAVR Durability Through 7 Years

Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Less Bivalirudin, Minimal Ultrasound: Survey Highlights Global Transradial Practice Patterns

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Procedural Success Increasing for CTO PCI in Europe, Despite More Complex Lesions

TAVR Superior to Surgery at Getting High-Risk Patients Home Sooner

Aging Data: Study Highlights Delays From Time of Clinical Trial Enrollment to Publication

No Harm Done: Foregoing Routine TEE and General Anesthesia in TAVR

Norepinephrine Bests Epinephrine in Battle of the Vasopressors in Cardiogenic Shock

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

iFR Pullback Provides Roadmap for CAD Severity, Predicts Hemodynamics Post-PCI

TCTMD’s Top 10 Most Popular Stories for January 2018

Preexisting Prosthesis-Patient Mismatch Signals Worse Aortic Valve-in-Valve Outcomes

Low Rate of Bailout Emergency Surgery During TAVR, but Caution Still Needed

REPRISE III in Print: Now With Comparison Between Lotus, Evolut R

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content